Nasal Decongestant
NDC Package 72103-333-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nasal Decongestant is usestemporarily relieves nasal congestion due to:common coldhay feverupper respiratory allergies. Marketed by The Ibn Sina Pharmaceutical Industry Ltd., this product is identified by NDC 72103-333 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
72103-333-15
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Product Code
72103-333
11-Digit Billing Format
72103033315
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nasal Decongestant
Dosage Form
-
Usage Information
Usestemporarily relieves nasal congestion due to:common coldhay feverupper respiratory allergies

Regulatory & Marketing

Labeler Name
The Ibn Sina Pharmaceutical Industry Ltd.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-12-2019
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72103-333-15 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 10 ml in 1 bottle, dropper of Nasal Decongestant, labeled by The Ibn Sina Pharmaceutical Industry Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Ibn Sina Pharmaceutical Industry Ltd. on March 12, 2019. The current certification is valid through December 31, 2020.

How is this The Ibn Sina Pharmaceutical Industry Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72103033315. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72103-333-15
11-Digit CMS (5-4-2)
72103-0333-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.